NYSE:CNMD
CONMED Corp
CONMED Corp's revenue grew 5.2% in fiscal 2025 to $1.4B while operating margin fell to 7.5%. Free cash flow was $150.9M, 11.0% of revenue.Summary generated from CONMED Corp's SEC filings. Latest annual report filed Feb 17, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.4B
Revenue growth+5.2%
Revenue, 5-yr CAGR+9.8%
Gross margin54.6%
Operating margin7.5%
Net margin3.4%
ROIC3.7%
Return on equity4.7%
Debt / equity0.81
Free cash flow$150.9M
FCF margin11.0%
Share count change−0.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 |
| Operating income | 110 | 70 | 121 | 200 | 103 |
| Net income | 63 | −81 | 64 | 132 | 47 |
| Free cash flow | 97 | 12 | 106 | 154 | 151 |
Recent filings
- 4Insider transaction report
Sep 10, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 29, 2026 - 8-KResults of operations and financial condition
Jul 29, 2026 - 4Insider transaction report
Jul 17, 2026 - 8-KDirector or officer change
Jun 17, 2026 - 8-KEntry into a material agreement
Jun 4, 2026 - 8-KEntry into a material agreement
Jun 1, 2026 - 8-KDirector or officer change
May 20, 2026